Abstract
Transient receptor potential melastatin 8 (TRPM8) is a non-selective cation channel activated by cold temperature and cooling agents. TRPM8 is expressed in a subpopulation of cold-sensitive sensory neurons, as well as in the male urogenital system. TRPM8 is markedly upregulated in prostate cancer and in other tumors such as breast adenocarcinoma and melanoma. Moreover, recent studies suggest the potential involvement of TRPM8 channels in the pathophysiology of cold nociception and cold allodynia. This has led to a strong interest in the pursuit of novel modulators of TRPM8 channels. This review highlights our current knowledge of TRPM8 pharmacology and modulation mechanisms, detailing structural features important for TRPM8 gating by different agonists, the mechanism of antagonism by different compounds and the potential relevance of TRPM8 for treatment of various pathological conditions.
Keywords: Cold, thermoreceptor, menthol, pain, prostate cancer, TRPM8 Channels, Transient receptor potential melastatin, breast adenocarcinoma, melanoma, cold nociception, cold allodynia, human prostate carcinoma, prostate epithelium, peripheral sensory neurons, TRPM8 modulators, TRPM8 gene, voltage-gated potassium (Kv) channels, putative phosphorylation sites, bladder urothelium, male urogenital tract, unmyelinated afferents, detrusor overactivity, neuroendocrine tumor, rat myocytes, vasomotor responses, trigeminal ganglia, TRPM8-expressing neurons, C-fibers, A fibers, S4-S5 linker, menthol affinity, Tyr745, Asp802, desensitization, voltage clamp errors, Calcium Imaging Microscopy, Patch-Clamp Electrophysiology, MWCmodel, WS-12, citronellal, geraniol, linalool, TRPM8 agonist, Leu1009, TRPV1, SKF96365, AMTB, Y745H mutant, HEK293 cells, hippocampal neurons, DRG neurons, Ser9, Thr17
Current Pharmaceutical Biotechnology
Title: The Emerging Pharmacology of TRPM8 Channels: Hidden Therapeutic Potential Underneath a Cold Surface
Volume: 12 Issue: 1
Author(s): Annika Malkia, Cruz Morenilla-Palao and Felix Viana
Affiliation:
Keywords: Cold, thermoreceptor, menthol, pain, prostate cancer, TRPM8 Channels, Transient receptor potential melastatin, breast adenocarcinoma, melanoma, cold nociception, cold allodynia, human prostate carcinoma, prostate epithelium, peripheral sensory neurons, TRPM8 modulators, TRPM8 gene, voltage-gated potassium (Kv) channels, putative phosphorylation sites, bladder urothelium, male urogenital tract, unmyelinated afferents, detrusor overactivity, neuroendocrine tumor, rat myocytes, vasomotor responses, trigeminal ganglia, TRPM8-expressing neurons, C-fibers, A fibers, S4-S5 linker, menthol affinity, Tyr745, Asp802, desensitization, voltage clamp errors, Calcium Imaging Microscopy, Patch-Clamp Electrophysiology, MWCmodel, WS-12, citronellal, geraniol, linalool, TRPM8 agonist, Leu1009, TRPV1, SKF96365, AMTB, Y745H mutant, HEK293 cells, hippocampal neurons, DRG neurons, Ser9, Thr17
Abstract: Transient receptor potential melastatin 8 (TRPM8) is a non-selective cation channel activated by cold temperature and cooling agents. TRPM8 is expressed in a subpopulation of cold-sensitive sensory neurons, as well as in the male urogenital system. TRPM8 is markedly upregulated in prostate cancer and in other tumors such as breast adenocarcinoma and melanoma. Moreover, recent studies suggest the potential involvement of TRPM8 channels in the pathophysiology of cold nociception and cold allodynia. This has led to a strong interest in the pursuit of novel modulators of TRPM8 channels. This review highlights our current knowledge of TRPM8 pharmacology and modulation mechanisms, detailing structural features important for TRPM8 gating by different agonists, the mechanism of antagonism by different compounds and the potential relevance of TRPM8 for treatment of various pathological conditions.
Export Options
About this article
Cite this article as:
Malkia Annika, Morenilla-Palao Cruz and Viana Felix, The Emerging Pharmacology of TRPM8 Channels: Hidden Therapeutic Potential Underneath a Cold Surface, Current Pharmaceutical Biotechnology 2011; 12 (1) . https://dx.doi.org/10.2174/138920111793937916
DOI https://dx.doi.org/10.2174/138920111793937916 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neurotrophin-3 Stimulates Migration of Mesenchymal Stem Cells Overexpressing TrkC
Current Medicinal Chemistry Realgar Nanoparticles Inhibit Migration, Invasion and Metastasis in a Mouse Model of Breast Cancer by Suppressing Matrix Metalloproteinases and Angiogenesis
Current Drug Delivery Rho GTPase Activating Proteins in Cancer Phenotypes
Current Protein & Peptide Science Blood-Brain Barrier ABC-transporter P-glycoprotein in Alzheimer's Disease: Still a Suspect?
Current Pharmaceutical Design Structural Basis and Therapeutic Implication of the Interaction of CCN Proteins with Glycoconjugates
Current Pharmaceutical Design Silica Nanoparticles as Promising Drug/Gene Delivery Carriers and Fluorescent Nano-Probes: Recent Advances
Current Cancer Drug Targets Recent Advances in Phenanthroindolizidine and Phenanthroquinolizidine Derivatives with Anticancer Activities
Anti-Cancer Agents in Medicinal Chemistry Significance of Metallothionein Expression in Liver Disease
Current Pharmaceutical Biotechnology Matrix Metalloproteinases and Vulnerable Atheromatous Plaque
Current Topics in Medicinal Chemistry Editorial [Hot topic: Recent Progress in Cancer Therapeutics (Guest Editor: Kurt S. Zaenker)]
Current Molecular Medicine Role of Retinoids, Rexinoids and Thyroid Hormone in the Expression of Cytochrome P450 Enzymes
Current Drug Metabolism Curcumin as a Natural Modulator of B Lymphocytes: Evidence from In Vitro and In Vivo Studies
Mini-Reviews in Medicinal Chemistry Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy
Current Cancer Drug Targets Malignant Hypercalcemia
Current Medicinal Chemistry Dendritoma Vaccine for Cancer: A Hopeful Approach
Current Cancer Therapy Reviews A Novel Sentinel Lymph Node Approach in Oral Squamous Cell Carcinoma
Current Pharmaceutical Design COX-2 Selective Inhibitors, Carbonic Anhydrase Inhibition and Anticancer Properties of Sulfonamides Belonging to This Class of Pharmacological Agents
Mini-Reviews in Medicinal Chemistry Raloxifene and Cardiovascular Health: Its Relationship to Lipid and Glucose Metabolism, Hemostatic and Inflammation Factors and Cardiovascular Function in Postmenopausal Women
Current Pharmaceutical Design Modulation of Host Cell Nucleocytoplasmic Trafficking During Picornavirus Infection
Infectious Disorders - Drug Targets Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer
Current Medicinal Chemistry